CHG-2024-0205

New Dosage Strength for Tisagenlecleux-B. Labeling Change for Tisagenlecleux-B — major revision. Impacts 2 markets and 3 variations.

Change Number
CHG-2024-0205
Type
New Dosage Strength
Product
Tisagenlecleux-B
Status
Blocked
Owner
Marcus Webb
Initiated
2022-08-11
Description

Labeling Change for Tisagenlecleux-B — major revision

Impacted Markets (2)
DE — GermanyBE — Belgium
Impacted Modules
3.2.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved